Ssociated with survival in NSCLC and might have a substantial part as prognostic markers in the illness. We discovered no partnership in between the CYP27B1 rs3782130, CYP27B1 rs10877012, CYP24A1 rs4809957, CYP2R1 rs10741657, VDR rs1544410, and VDR rs2228570 polymorphisms and survival in our patients.Supplementary Materials: The following are obtainable on the internet at mdpi/article/10 .3390/nu13113783/s1, Table S1: Clinical qualities and association with general survival with the 194 NSCLC sufferers. Table S2: Clinical qualities and association with progression-free survival of the 194 NSCLC individuals. Table S3: Clinical traits and association with all round survival with the resected NSCLC sufferers. Table S4: Clinical traits and association with progressionfree survival of the resected NSCLC individuals. Table S5: Clinical qualities and association with general survival with the non-resected NSCLC patients. Table S6: Clinical 16 Prostaglandin Receptor characteristics and association with progression-free survival of the non-resected NSCLC individuals. Table S7: Minor allele frequencies of SNPs. Table S8: Hardy einberg Equilibrium (OS). Table S9: Hardy einberg Equilibrium (PFS). Table S10: Linkage disequilibrium. Table S11: Polymorphisms and association with general survival on the 194 NSCLC individuals. Table S12: Polymorphisms and association with progression-free survival on the 194 NSCLC patients. Table S13: Polymorphisms and association with overall survival from the resected NSCLC sufferers. Table S14: Polymorphisms and association with general survival of the non-resected NSCLC individuals. Table S15: Polymorphisms and association with progression-free survival on the resected NSCLC individuals. Table S16: Polymorphisms and association with progression-free survival in the non-resected NSCLC sufferers. Figure S1. Kaplan eier plot of general survival curves by gender in 194 patients with NSCLC. Figure S2. Kaplan eier plot of all round survival curves by drinking status in 194 individuals with NSCLC. Figure S3. Kaplan eier plotNutrients 2021, 13,16 ofof general survival curves by tumor stage in 194 sufferers with NSCLC. Figure S4. Kaplan eier plot of general survival curves by first-line therapy (divided by surgery) in 194 sufferers with NSCLC. Figure S5. Kaplan eier plot of progression-free survival curves with preceding lung illness in 194 individuals with NSCLC. Figure S6. Kaplan eier plot of progression-free survival curves by drinking status in 194 individuals with NSCLC. Figure S7. Kaplan eier plot of progression-free survival curves by tumor stage in 194 patients with NSCLC. Figure S8. Kaplan eier plot of progression-free survival curves by first-line therapy (divided by surgery) in 194 patients with NSCLC. Figure S9. Kaplan eier plot of overall survival curves with loved ones history of cancer in the resected NSCLC subgroup. Figure S10. Kaplan eier plot of progression-free survival curves by tumor stage within the resected NSCLC subgroup. Figure S11. Kaplan eier plot of overall survival curves by gender within the non-resected NSCLC subgroup. Figure S12. Kaplan eier plot of all round survival curves by drinking status within the non-resected NSCLC subgroup. Figure S13. Kaplan eier plot of general survival curves by tumor stage within the non-resected NSCLC subgroup. Figure S14. Kaplan eier plot of progression-free survival curves by physique mass index inside the non-resected NSCLC subgroup. Figure S15. Kaplan eier plot of overall survival curves with all the T allele of the GC QX-314 References rs7041 gene polymorphis.
